Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

12 Dec 2008 11:00

RNS Number : 0326K
Gleeson(M J)Group PLC
12 December 2008
 



12 December 2008

M J GLEESON GROUP PLC

Board Changes

Resignation of Paul Wallwork as Group Chief Executive

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces the resignation of Paul Wallwork as Group Chief Executive with effect from 31 December 2008

Paul Wallwork, ACA, BA (Hons), 46, was appointed to the Board in January 2006 as Group Finance Director. He was appointed Group Chief Executive in January 2007 having previously served as Interim Group Chief Executive since July 2006. He previously held senior financial and management roles with Inchcape plc and senior financial roles with Brent International plc.

Dermot Gleeson, Non-executive Chairman, stated "I would like to thank Paul for his strong and energetic leadership of the Gleeson Group through an extremely challenging period. He has ensured that the Group is well placed to meet the tough challenges faced by all housebuilders in the current market conditions."

Appointment of Group Chief Executive

Gleeson is pleased to announce the appointment as Group Chief Executive, with effect from 1 January 2009, of Chris Holt who, since 1 May 2007, has been Group Finance Director and prior to that held the position of Interim Group Finance Director from August 2006.

Nicholas Christopher Holt, BSc, MBA, CIMA, 57, has obtained a wealth of financial and management experience at senior level with internationally renowned businesses, namely Foster Wheeler (1987-2005) and Bechtel (1975-87). 

Dermot Gleesonstated "As Group Finance Director, Chris has made a hugely important contribution to the successful restructuring of the Group, and his skills and experience mean that he is very well equipped to provide the effective leadership that Gleeson will continue to need in an exceptionally difficult economic environment."

Appointment of Group Finance Director

To replace Chris Holt, Gleeson is pleased to announce the appointment of Alan Martin as Group Finance Director with effect from 1 January 2009. Alan is currently Group Financial Controller, a position he has held since November 2006.

Alan Martin, BSc (Hons), ACA, 42, qualified as a Chartered Accountant in 1990, following which he joined Price Waterhouse where he specialised in corporate recovery in both London and SydneyAustralia. Assignments included secondment as Advisor to National Australia Bank. In 2000, he joined Psion PLC, where he held a number of senior management roles, the most recent being Group Financial Controller.

Alan Martin has held no directorship in any other publicly quoted company at any time in the previous five years and there are no details to be disclosed under paragraph 9.6.13 R of the Listing Rules.

Dermot Gleeson stated "I am delighted that Alan has joined the Board to which he has the potential to make an extremely valuable contribution." 

Enquiries:

M J Gleeson Group plc 01252 360300

Chris Holt (Group Chief Executive, Designate)

Alan Martin (Group Finance Director, Designate)

Bankside Consultants Limited

Charles Ponsonby  020 7367 8851

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKBKNKBDDFBD
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.